Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -58.33% is in line with its 3-year average of -58.77%, near the high end of its 3-year range (-174.30%–-36.98%).
29.16% above its 12-month average of -82.35%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -59.11%.
NET PROFIT MARGIN
-58.33%
NET PROFIT MARGIN AVG TTM
-82.35%
NET PROFIT MARGIN AVG 3Y
-55.66%
NET PROFIT MARGIN AVG 5Y
N/A
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+29.16%
CURRENT VS 3Y AVG
-4.80%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
9.21%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
-733.68%
vs the sector median at left
Shoulder Innovations, Inc.
Market Cap
$376.61M
Net Profit Margin
-58.33%
TTM Avg
-82.35%
3Y Avg
-55.66%
5Y Avg
N/A
Market Cap
$45.05M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.14B
Net Profit Margin
-7.13%
TTM Avg
-23.45%
3Y Avg
-155.72%
5Y Avg
-114.72%
Market Cap
$1.91B
Net Profit Margin
-14.99%
TTM Avg
-20.12%
3Y Avg
-16.95%
5Y Avg
-10.04%
Market Cap
$2.99B
Net Profit Margin
22.69%
TTM Avg
19.73%
3Y Avg
-2.42%
5Y Avg
-44.65%
Market Cap
$5.10B
Net Profit Margin
9.22%
TTM Avg
8.68%
3Y Avg
7.83%
5Y Avg
5.80%
Market Cap
$5.59B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-101.30%
5Y Avg
-277.86%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Shoulder Innovations, Inc. (SI) | $376.61M | -58.33% | -82.35% | -55.66% | N/A |
| NRC Health (NRC)vs › | $463.35M | 4.18% | 12.88% | 16.89% | 20.14% |
| PDS Biotechnology Corporation (PDSB)vs › | $45.05M | 0.00% | 0.00% | 0.00% | 0.00% |
| Teladoc Health, Inc. (TDOC)vs › | $1.14B | -7.13% | -23.45% | -155.72% | -114.72% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.91B | -14.99% | -20.12% | -16.95% | -10.04% |
| TransMedics Group, Inc. (TMDX)vs › | $2.99B | 22.69% | 19.73% | -2.42% | -44.65% |
| Doximity, Inc. (DOCS)vs › | $4.88B | 25.48% | 34.77% | 31.87% | 32.80% |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.10B | 9.22% | 8.68% | 7.83% | 5.80% |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.59B | 0.00% | 0.00% | -101.30% | -277.86% |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.24B | -5.51% | 7.00% | -0.29% | -8.82% |
Operating Margin
-58.5%
Net Profit Margin
-58.3%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -59.11% |
| 2026-03-31 | -50.15% |
| 2025-12-31 | -53.91% |
| 2025-09-30 | -74.25% |
| 2025-06-30 | -174.30% |
| 2025-03-31 | -46.01% |
| 2024-12-31 | -43.46% |
| 2024-09-30 | -54.40% |
| 2024-06-30 | -50.51% |
| 2024-03-31 | -50.11% |
| 2023-12-31 | -36.98% |
| 2023-09-30 | -84.93% |
| 2023-06-30 | -64.07% |
| 2023-03-31 | -96.09% |
